Skip to content
HPR Logo
My Request
  • Home
  • About Us
    • Health Psychology Research Ltd.
    • Our Team
    • Our Goals
  • Questionnaires
    • Find a Questionnaire
    • Languages Available
    • My Request
    • Summary Guidelines
  • Linguistic Validation
  • News
  • Research
    • Current Research
    • Publications & Posters
  • FAQs
  • Contact Us
  • Home
  • About Us
    • Health Psychology Research Ltd.
    • Our Team
    • Our Goals
  • Questionnaires
    • Find a Questionnaire
    • Languages Available
    • My Request
    • Summary Guidelines
  • Linguistic Validation
  • News
  • Research
    • Current Research
    • Publications & Posters
  • FAQs
  • Contact Us

Validation of the Study Medication Satisfaction Questionnaire (SMSQ). A measure of medication satisfaction designed for individuals taking Pre-exposure Prophylaxis (PrEP) medication for HIV.

Romaine J, Murray M and Bradley C
01/11/2019

Value in Health Volume 22, Supplement 3S638

Poster presented at the ISPOR Annual European Conference, Copenhagen, Denmark 2nd – 6th November 2019

OBJECTIVES: The Study Medication Satisfaction Questionnaire status version (SMSQs) is a new measure designed for studies evaluating medication for HIV prevention (pre-exposure prophylaxis: PrEP) where participants do not have HIV. Adapted from the HIV Treatment Satisfaction Questionnaire (HIVTSQ) the SMSQs includes all aspects of treatment included in the HIVTSQ (e.g. convenience, side-effects). However, refers only to current ‘study medication’. This abstract reports the psychometric properties of the SMSQs.

METHODS: Data were from week 18 of the ÉCLAIR trial (NCT02076178): a randomised placebo-controlled clinical trial evaluating safety, tolerability and acceptability of cabotegravir long acting (LA) injectable formulation. Participants included healthy men, at low risk of contracting HIV, randomly assigned (5:1) to receive cabotegravir or placebo. By week 18, participants had received a once-daily oral cabotegravir (30mg) or placebo tablet for 4 weeks, and two intra-muscular injections of cabotegravir LA (800mg) or saline placebo (each at weeks 5 & 17). Data were available for 112 participants. The SMSQ includes 11 items exploring different aspects of medication satisfaction, rated on 7-point scales (e.g. 6 ‘very satisfied’ to 0 ‘very dissatisfied’).

RESULTS: Exploratory Factor Analysis (EFA) of the 11-item SMSQ revealed a clean one-factor structure explaining 65% of the variance. All items loaded >0.65. Internal consistency reliability was excellent (alpha=0.95). Repeated EFA explored use of an easy/difficult item as a potential alternative to the demands, flexibility and convenience items. No one combination demonstrated a superior solution (in each run loadings >0.63, explained variance >60 percent, alpha>0.91).

CONCLUSIONS: The SMSQ is an up-to-date appropriate measure of medication satisfaction for individuals at risk of HIV infection taking PrEP medication. Two versions of the SMSQs are available. For a more detailed analysis of medication satisfaction the full 11-item version is recommended. When brevity is paramount, an 8-item short-form (excluding demands, convenience and flexibility) can be used.

Link to publication
HPR Logo footer
  • About Us
  • Questionnaires
  • Website terms of use
  • Privacy policy
  • Cookie policy
  • Cookie settings
  • About Us
  • Questionnaires
  • Website terms of use
  • Privacy policy
  • Cookie policy
  • Cookie settings
Cyber Essentials logo
  • About Us
  • Questionnaires
  • Website terms of use
  • Privacy policy
  • Cookie policy
  • Cookie settings
  • About Us
  • Questionnaires
  • Website terms of use
  • Privacy policy
  • Cookie policy
  • Cookie settings

© 2026 Health Psychology Research Ltd. Company no. 4803452

We'd like to use analytics cookies to see how our website is used so we can improve it. They are only set if you accept. Cookie policy